The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Overall survival from the phase 3 POLO trial: Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer.
 
Talia Golan
Honoraria - MSD; Rafael Pharmaceuticals
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; MSD; Teva
Speakers' Bureau - Abbvie; AstraZeneca
Research Funding - AstraZeneca (Inst); MSD (Inst)
Travel, Accommodations, Expenses - AstraZeneca; MSD
 
Pascal Hammel
Honoraria - Celgene
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; ERYTECH Pharma (Inst); Halozyme; Mylan; Rafael Pharmaceuticals; VECT-HORUS
Speakers' Bureau - AstraZeneca; Celgene; ERYTECH Pharma; SERVIER; Shire
Research Funding - AstraZeneca (Inst); Celgene (Inst); ERYTECH Pharma (Inst); Halozyme (Inst)
Travel, Accommodations, Expenses - Halozyme; Ipsen; Pfizer/EMD Serono; Shire; Vect-Horus
 
Michele Reni
Consulting or Advisory Role - AstraZeneca; Baxalta/Shire; Baxter; Celgene; Lilly; Sanofi
Research Funding - Celgene
Travel, Accommodations, Expenses - Celgene
Other Relationship - AstraZeneca; Celgene
 
Eric Van Cutsem
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Bayer; Biocartis; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; GlaxoSmithKline; Halozyme; Incyte; Lilly; Merck KGaA; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche; SERVIER; Sirtex Medical; Taiho Pharmaceutical
Research Funding - amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Merck KGaA (Inst); Novartis (Inst); Roche (Inst); SERVIER (Inst)
 
Teresa Macarulla
Consulting or Advisory Role - Baxalta; Baxter; Celgene; Incyte; Ipsen; Lilly; QED Therapeutics; Roche; Sanofi/Aventis; SERVIER; Shire
Research Funding - Agios (Inst); ASLAN Pharmaceuticals (Inst); AstraZeneca (Inst); Bayer (Inst); Celgene (Inst); Genentech (Inst); Halozyme (Inst); Immunomedics (Inst); Lilly (Inst); Merrimack (Inst); Millennium (Inst); Novartis (Inst); Novocure (Inst); Pfizer (Inst); Pharmacyclics (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Celgene; H3 Biomedicine; Merck; Sanofi; SERVIER
 
Michael J. Hall
Research Funding - Ambry Genetics; AstraZeneca; Caris Life Sciences; Foundation Medicine; InVitae; Myriad Genetics
Patents, Royalties, Other Intellectual Property - I share a patent with several Fox Chase investigators for a novel method to investigate hereditary CRC genes (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Caris Life Sciences; Foundation Medicine; Myriad Genetics
Other Relationship - Caris Life Sciences; Foundation Medicine; Invitae; Myriad Genetics
 
Joon Oh Park
Consulting or Advisory Role - AstraZeneca; Celgene; GI Innovation; Merck Serono; SERVIER
Speakers' Bureau - Celgene
Research Funding - Celgene; medpacto
 
Daniel Hochhauser
Stock and Other Ownership Interests - Novartis; Roche
Speakers' Bureau - Pierre Fabre
Research Funding - Merck Serono
Travel, Accommodations, Expenses - Celgene
 
Dirk Arnold
Honoraria - Bayer; Bristol-Myers Squibb; Merck Serono; Roche/Genentech; SERVIER; TERUMO
Consulting or Advisory Role - Bayer; Biocompatibles; Bristol-Myers Squibb; Merck Serono; MSD Oncology; Servier; Terumo
Research Funding - Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche/Genentech
 
Do-Youn Oh
Consulting or Advisory Role - ASLAN Pharmaceuticals; AstraZeneca; Bayer; Celgene; Genentech/Roche; Halozyme; Merck Serono; Novartis; Taiho Pharmaceutical; Zymeworks
Research Funding - Array BioPharma; AstraZeneca; Lilly; Novartis
 
Anke C. Reinacher-Schick
Honoraria - Amgen; AstraZeneca; Aurikamed; Baxalta; BOVita; Bristol-Myers Squibb; Celgene; iomedico; Lilly; MCI Group; med publico; Merck Serono; MSD; Pfizer; Promedior; Roche; Sanofi/Aventis; SERVIER; Shire
Consulting or Advisory Role - Amgen; AstraZeneca; Baxalta; Bristol-Myers Squibb; Celgene; Merck Serono; MSD; Onkowissen; Pfizer; Pierre Fabre; Roche; Sanofi/Aventis; SERVIER
Research Funding - AIO-Studien (Inst); Alexion Pharmaceuticals (Inst); Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Georgius Agricola Stiftung Ruhr (Inst); Ipsen (Inst); Lilly (Inst); Ludwig Maximilian University of Munich (Inst); MOLOGEN (Inst); Pharma Consulting Group AB (Inst); PPD Global (Inst); Roche (Inst); Servier (Inst); Syneed Medidata (Inst); University of Cologne (Inst); University of Erlangen-Nuremberg (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Celgene; Ipsen; MCI Group; Merck Serono; MSD; Onkowissen; Pierre Fabre; Roche; Servier
 
Giampaolo Tortora
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; MSD
 
Hana Algül
Consulting or Advisory Role - Celgene; SERVIER
Research Funding - Chugai Pharma (Inst)
Travel, Accommodations, Expenses - SERVIER
 
Eileen Mary O'Reilly
Consulting or Advisory Role - Agios (I); AstraZeneca (I); Autem Medical (I); Bayer (I); BeiGene (I); Berry Genomics (I); Celgene (I); CytomX Therapeutics; Debiopharm Group (I); Eisai (I); Exelixis/Ipsen (I); Flatiron Health (I); Genentech/Roche (I); Gilead Sciences (I); Incyte (I); Ipsen (I); Janssen; LAM Therapeutics (I); Lilly (I); Loxo; Merck; Minapharma (I); QED Therapeutics (I); RedHill Biopharma (I); Silenseed; Sillajen (I); SOBI; TheraBionic (I); twoXAR; Vector Health (I); Yiviva (I)
Research Funding - Acta Biologica (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Halozyme (Inst); MabVax (Inst); Roche (Inst); Silenseed (Inst)
 
David McGuinness
Employment - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Karen Cui
Employment - AstraZeneca
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Katia Schlienger
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
Gershon Y. Locker
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Hedy L. Kindler
Honoraria - AstraZeneca
Consulting or Advisory Role - Aldeyra Therapeutics; Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Deciphera; ERYTECH Pharma; Five Prime Therapeutics; Inventiva Pharma; Inventiva Pharma; ipsen; Kyowa Hakko Kirin; Merck; Paradox Therapeutics
Research Funding - Aduro Biotech (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Deciphera (Inst); GlaxoSmithKline (Inst); Inhibrx (Inst); Leap Therapeutics (Inst); Lilly (Inst); Macrogenics (Inst); MedImmune (Inst); Merck (Inst); Polaris (Inst); Polaris (Inst); Roche/Genentech (Inst); Tesaro (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - AstraZeneca